🏛 Organisation

McMaster University

1 story First seen Jul 19, 2026 Latest Jul 19, 2026

🧬 AI profile — grown from 6ic coverage McMaster University is a public research university located in Hamilton, Ontario, Canada. The university's researchers have been involved in studies exploring potential treatments for Long COVID, including a recent trial that found the medication fluvoxamine shows promise in reducing fatigue associated with the condition.

Coverage by desk

Science 1

Coverage · last 14 days

Jul 7Jul 20

Recurring themes

long COVID ×1 fluvoxamine ×1 Brazil ×1 clinical trial ×1

🕸 Connection map 🌌 Full galaxy →

Connected entities

Metformin ×1 University of British Columbia ×1 SARS-CoV-2 ×1 COVID ×1 Stanford University ×1 REVIVE-TOGETHER ×1 Brazilian ×1 Fluvoxamine ×1 Brazil ×1

Every story (1)

Breakthrough in Long COVID Treatment: Fluvoxamine Shows Promise in Reducing Fatigue

Science · Jul 19, 2026 · BlockchainSpace AI